(Q34622466)

3 August 2017

1 reference

title

Non-nucleoside inhibitors of herpesviruses (English)

1 reference

3 August 2017

Michael W Wathen

1

1 reference

3 August 2017

publication date

1 May 2002

1 reference

Reviews in Medical Virology

3 August 2017

published in

1 reference

3 August 2017

volume

12

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

167-178

1 reference

3 August 2017

1 reference

21 January 2018

1 reference

Herpes simplex virus latency and nucleoside analogues

21 January 2018

1 reference

Viral infections after renal transplantation

21 January 2018

1 reference

21 January 2018

Herpes simplex viruses

1 reference

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

21 January 2018

1 reference

Human cytomegalovirus: challenges, opportunities and new drug development

21 January 2018

1 reference

Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients

21 January 2018

1 reference

Herpes zoster in older adults

21 January 2018

1 reference

Herpes zoster: focus on treatment in older adults

21 January 2018

1 reference

Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections

21 January 2018

1 reference

Recent strategies in the development of new human cytomegalovirus inhibitors.

21 January 2018

1 reference

Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase

21 January 2018

1 reference

Targeting the HIV-protease in AIDS therapy: a current clinical perspective

21 January 2018

1 reference

Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles

21 January 2018

1 reference

A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products

21 January 2018

1 reference

Structure-activity relationships of acyloxyamidine cytomegalovirus DNA polymerase inhibitors

21 January 2018

1 reference

Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase

21 January 2018

1 reference

Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses

21 January 2018

1 reference

Broad-spectrum antiherpes activities of 4-hydroxyquinoline carboxamides, a novel class of herpesvirus polymerase inhibitors

21 January 2018

1 reference

Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir

21 January 2018

1 reference

Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo

21 January 2018

1 reference

Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections

21 January 2018

1 reference

A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site

21 January 2018

1 reference

Cloning and sequence analysis of murine cytomegalovirus protease and capsid assembly protein genes

21 January 2018

1 reference

Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad.

21 January 2018

1 reference

Unique fold and active site in cytomegalovirus protease

21 January 2018

1 reference

Three-dimensional structure of human cytomegalovirus protease

21 January 2018

1 reference

A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease

21 January 2018

1 reference

Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease

21 January 2018

1 reference

Herpesvirus proteases: targets for novel antiviral drugs

21 January 2018

1 reference

The herpesvirus proteases as targets for antiviral chemotherapy

21 January 2018

1 reference

Inhibition of herpes proteases and antiviral activity of 2-substituted thieno[2,3-d]oxazinones

21 January 2018

1 reference

Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism

21 January 2018

1 reference

Antiviral properties of a series of 1,6-naphthyridine and 7, 8-dihydroisoquinoline derivatives exhibiting potent activity against human cytomegalovirus

21 January 2018

1 reference

Discovery of 1,6-naphthyridines as a novel class of potent and selective human cytomegalovirus inhibitors

21 January 2018

1 reference

Isoquinoline-6-carboxamides as potent and selective anti-human cytomegalovirus (HCMV) inhibitors

21 January 2018

1 reference

Substituted 1,6-naphthyridines as human cytomegalovirus inhibitors: conformational requirements

21 January 2018

1 reference

Post-transplant lymphoproliferative disease in children

21 January 2018

1 reference

Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: case-control and historical cohort studies

21 January 2018

1 reference

Novel agents for the treatment of human cytomegalovirus infection

21 January 2018

1 reference

Recent advances in antiviral research: identification of inhibitors of the herpesvirus proteases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.354

1 reference

3 August 2017

1 reference